State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 315 actively recruiting studies with Michigan sites out of 315 registered in total. The busiest research areas in Michigan are Advanced Solid Tumors, Triple Negative Breast Cancer, Prostate Cancer. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), Eli Lilly and Company. By stage, Michigan trials break down as Phase 1 (52), Phase 2 (98), Phase 3 (88), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 315 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 315. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumors, Triple Negative Breast Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT06585774 Phase 3
Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chro...
Condition
Chronic Graft-versus-host-disease
Enrollment
240 pts
Location
United States, Australia, Austria
Sponsor
Incyte Corporation
NCT06463340 Phase 1
Recruiting
Study of SGR-3515 In Participants With Advanced Solid Tumors.
Condition
Advanced Solid Tumor
Enrollment
52 pts
Location
United States, Canada
Sponsor
Schrödinger, Inc.
NCT07602582 Phase 3
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAIL...
Condition
Alzheimer Disease
Enrollment
550 pts
Location
United States, Japan, Puerto Rico
Sponsor
Eli Lilly and Company
NCT04553523 N/A
Recruiting
Hydrus® Microstent New Enrollment Post-Approval Study
Condition
Primary Open Angle Glaucoma
Enrollment
545 pts
Location
United States
Sponsor
Alcon Research
NCT06898515 Phase 3
Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Repr...
Condition
Acute Decompensated Heart Failure
Enrollment
400 pts
Location
United States, Germany, Italy
Sponsor
Reprieve Cardiovascular, Inc
NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06825897 N/A
Recruiting
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With...
Condition
Stroke, Acute
Enrollment
2,039 pts
Location
United States
Sponsor
Santiago Ortega Gutierrez
NCT05541822 Phase 2
Recruiting
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of AB...
Condition
Advanced Solid Tumors
Enrollment
178 pts
Location
United States, South Korea, Taiwan
Sponsor
Abion Inc
NCT07076082 Phase 4
Recruiting
Vascular Trial Associated Registry Pilot
Condition
Peripheral Arterial Disease
Enrollment
350 pts
Location
United States
Sponsor
Corewell Health West
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT04121780 Phase 2
Recruiting
Growth Hormone Replacement Therapy for Retried Professional Football Players
Condition
TBI (Traumatic Brain Injury)
Enrollment
42 pts
Location
United States
Sponsor
Center for Neurological Studie
NCT01241305 N/A
Recruiting
One-Time DNA Study for Vasculitis
Condition
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Enrollment
1,000 pts
Location
United States, Canada, Turkey (Türkiye)
Sponsor
University of Pennsylvania
NCT06679270 Phase 3
Recruiting
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipo...
Condition
Familial Partial Lipodystrophy
Enrollment
24 pts
Location
United States
Sponsor
Chiesi Farmaceutici S.p.A.
NCT07244341 Phase 1
Recruiting
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastati...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
60 pts
Location
United States, China, Ireland
Sponsor
Daiichi Sankyo
NCT06045754 Phase 4
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Usteki...
Condition
Crohn's Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Takeda
NCT05922761 Phase 2
Recruiting
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Condition
Bronchiolitis Obliterans Syndrome
Enrollment
45 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT05445583 N/A
Recruiting
Asthma and Technology in Emerging African American Adults
Condition
Asthma
Enrollment
180 pts
Location
United States
Sponsor
University of Michigan
NCT07263594 Phase 1, Phase 2
Recruiting
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
Condition
Gastrointestinal Cancer
Enrollment
127 pts
Location
United States, Australia, China
Sponsor
DualityBio Inc.
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT06935357 Phase 3
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immun...
Condition
Immunoglobulin A Nephropathy (IgAN)
Enrollment
454 pts
Location
United States, Argentina, Australia
Sponsor
Biogen
NCT07701161 N/A
Recruiting
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease U...
Condition
Alzheimer s Disease
Enrollment
1,000 pts
Location
United States
Sponsor
Neurogen Biomarking LLC
NCT06915753 Phase 1
Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellula...
Condition
Metastatic Hepatocellular Carcinoma
Enrollment
100 pts
Location
United States, Canada, South Korea
Sponsor
Tyra Biosciences, Inc
NCT05009394 N/A
Recruiting
Surgical Treatments for Postamputation Pain
Condition
Residual Limb Pain
Enrollment
110 pts
Location
United States, Australia, Canada
Sponsor
Prometei Pain Rehabilitation C
NCT06401356 Phase 3
Recruiting
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Condition
Hematologic Malignancy
Enrollment
50 pts
Location
United States, Belgium, Italy
Sponsor
Novartis Pharmaceuticals
NCT04879329 Phase 2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer Th...
Condition
Urothelial Carcinoma
Enrollment
372 pts
Location
United States, Argentina, Australia
Sponsor
Seagen, a wholly owned subsidi
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology